Nilotinib is superior to imatinib as first-line therapy of...

Expert Review of Hematology 2010 / 12 Vol. 3; Iss. 6

Nilotinib is superior to imatinib as first-line therapy of chronic myeloid leukemia: the ENESTnd study

Giles, Francis J, Rosti, Gianantonio, Beris, Photis, Clark, Richard E, le Coutre, Philipp, Mahon, Francois-Xavier, Steegmann, Juan-Luis, Valent, Peter, Saglio, Giuseppe
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
3
Language:
english
Journal:
Expert Review of Hematology
DOI:
10.1586/ehm.10.61
Date:
December, 2010
File:
PDF, 731 KB
english, 2010
Conversion to is in progress
Conversion to is failed